Lipid Peroxidation as a Possible Factor Affecting Bone Resorption in Obese Subjects-Preliminary Research.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Jul 2023
Historique:
received: 28 06 2023
revised: 12 07 2023
accepted: 14 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Oxidative stress, which promotes bone catabolism, also affects the quality of bone tissue. We aimed to assess the impact of metabolic disorders and oxidant-antioxidant imbalance associated with primary obesity on bone resorption and formation processes. Anthropometric parameters, metabolic variables, oxidative stress indicators (malondialdehyde, vitamins A and E, uric acid, superoxide dismutase, catalase, glutathione peroxidase, type 1 paraoxonase, iron-reducing plasma antioxidant power) and markers of bone turnover (type I procollagen N-terminal propeptide and the type I collagen C-terminal cross-linked telopeptide; P1NP and CTX) were assessed in 108 Polish participants. Under the influence of oxidative stress, both enzymatic and non-enzymatic defense mechanisms were stimulated in obese subjects, especially in women, who had increased lipid peroxidation and activity of catalase (particularly in first-degree obesity) and decreased vitamin E concentration. The process of lipid peroxidation, as well as the weakening of the bone formation, was strongly manifested in women at a BMI range of 35.0-39.9 kg/m

Identifiants

pubmed: 37511388
pii: ijms241411629
doi: 10.3390/ijms241411629
pmc: PMC10380302
pii:
doi:

Substances chimiques

Antioxidants 0
Catalase EC 1.11.1.6
Procollagen Type I 0
Collagen Type I 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Med Assoc Thai. 2011 Oct;94 Suppl 5:S10-6
pubmed: 22338920
Anal Biochem. 1996 Jul 15;239(1):70-6
pubmed: 8660627
Curr Opin Rheumatol. 2015 Jul;27(4):414-9
pubmed: 26002034
BMC Musculoskelet Disord. 2020 Sep 10;21(1):603
pubmed: 32912188
Endocrinology. 2005 Feb;146(2):728-35
pubmed: 15528306
Bone. 2020 Apr;133:115230
pubmed: 31954199
BMC Musculoskelet Disord. 2021 Mar 7;22(1):253
pubmed: 33678168
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Cells. 2022 Sep 15;11(18):
pubmed: 36139457
Clin Chem Lab Med. 2011 Aug;49(8):1271-1274
pubmed: 21605012
BMC Endocr Disord. 2014 Feb 01;14:9
pubmed: 24484869
Calcif Tissue Int. 2000 Feb;66(2):100-3
pubmed: 10652955
Int J Obes (Lond). 2005 Jan;29(1):142-5
pubmed: 15467775
J Bone Miner Res. 2015 May;30(5):920-8
pubmed: 25400253
Methods Enzymol. 1978;52:302-10
pubmed: 672633
Bone. 2015 Mar;72:65-70
pubmed: 25460573
Endocrinology. 2008 Dec;149(12):6065-75
pubmed: 18687779
J Med Genet. 1976 Oct;13(5):337-42
pubmed: 1003443
J Lab Clin Med. 1967 Jul;70(1):158-69
pubmed: 6066618
Bone. 2004 Mar;34(3):557-61
pubmed: 15003803
Nutrients. 2017 Feb 03;9(2):
pubmed: 28165362
J Bone Miner Res. 2002 Nov;17(11):1997-2003
pubmed: 12412807
J Biol Chem. 1952 Mar;195(1):133-40
pubmed: 14938361
J Bone Miner Res. 2014 Jan;29(1):223-33
pubmed: 23775829
Bone. 2009 Aug;45(2):174-9
pubmed: 19446053
Mol Nutr Food Res. 2015 Jan;59(1):75-93
pubmed: 25418549
J Agric Food Chem. 2005 Mar 23;53(6):1841-56
pubmed: 15769103
Osteoporos Int. 2011 Feb;22(2):391-420
pubmed: 21184054
J Biol Chem. 1972 May 25;247(10):3170-5
pubmed: 4623845
Endocrinology. 2007 May;148(5):2553-62
pubmed: 17317771
Eur Heart J. 2013 Feb;34(5):389-97
pubmed: 22947612
J Clin Endocrinol Metab. 2005 Jul;90(7):4145-50
pubmed: 15855252
Am J Med. 2009 May;122(5):409-14
pubmed: 19375545
Mol Med Rep. 2022 Apr;25(4):
pubmed: 35211757
Circ Res. 2016 May 27;118(11):1752-70
pubmed: 27230640
J Bone Miner Res. 2008 Feb;23(2):205-14
pubmed: 17937534
J Bone Miner Res. 2003 May;18(5):859-67
pubmed: 12733725
Gynecol Endocrinol. 2007;23(8):451-4
pubmed: 17852412
Osteoporos Int. 2005 Nov;16(11):1330-8
pubmed: 15928804
Mol Cell Biochem. 2007 Jan;295(1-2):45-52
pubmed: 16841180
Bone. 2003 Jan;32(1):8-14
pubmed: 12584030
Inflamm Bowel Dis. 2007 Apr;13(4):416-23
pubmed: 17206686
BMC Musculoskelet Disord. 2021 Sep 6;22(1):759
pubmed: 34488720
Endocr Res. 2003 Aug;29(3):317-25
pubmed: 14535633
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):725-738
pubmed: 30449551
Osteoporos Int. 2017 Jul;28(7):2103-2113
pubmed: 28455749
Arch Toxicol. 1998 Mar;72(4):219-26
pubmed: 9587017
Clin Hemorheol Microcirc. 2005;33(1):41-6
pubmed: 16037631
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Ageing Res Rev. 2019 Nov;55:100946
pubmed: 31437484
Biochem Biophys Res Commun. 2004 Sep 3;321(4):845-50
pubmed: 15358104
J Cell Sci. 1992 Jun;102 ( Pt 2):341-51
pubmed: 1400636
Int J Endocrinol. 2014;2014:309570
pubmed: 24527032
Analyst. 2002 Jan;127(1):183-98
pubmed: 11827390
Eat Weight Disord. 2018 Jun;23(3):293-302
pubmed: 29637521
Calcif Tissue Int. 2014 Feb;94(2):223-31
pubmed: 24077896
Diabetes. 1998 Oct;47(10):1643-9
pubmed: 9753305
Methods Enzymol. 1990;186:407-21
pubmed: 2233308

Auteurs

Marcin Maciejewski (M)

Clinical Department of Orthopedics and Traumatology of the Musculoskeletal System, Antoni Jurasz University Hospital in Bydgoszcz, M. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland.

Joanna Siódmiak (J)

Department of Laboratory Diagnostics, Collegium Medicum, Nicolaus Copernicus University, M. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland.

Bartłomiej Borkowski (B)

Clinical Department of Orthopedics and Traumatology of the Musculoskeletal System, Antoni Jurasz University Hospital in Bydgoszcz, M. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland.

Matthias Lorkowski (M)

Clinical Department of Orthopedics and Traumatology of the Musculoskeletal System, Antoni Jurasz University Hospital in Bydgoszcz, M. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland.

Dorota M Olszewska-Słonina (DM)

Department of Pathobiochemistry and Clinical Chemistry, Collegium Medicum, Nicolaus Copernicus University, M. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH